Amanote Research
Register
Sign In
P025 Which Is the Optimal Immunotherapy for Advanced Non-Squamous Non-Small-Cell Lung Cancer in Combination With Chemotherapy?
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.10.049
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
December 1, 2018
Authors
H. Zhoum
Y. Zhang
G. Chen
S. Zhao
J. Liu
S. Hong
L. Zhang
Publisher
Elsevier BV
Related search
Bevacizumab Combination Chemotherapy in Clinical Practice for Advanced Non-Squamous Non-Small Cell Lung Cancer
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
P3.01-70 Meta-Analysis of Metformin in Combination With Platinum Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Palliative Chemotherapy for Advanced Non-Small Cell Lung Cancer
BMJ
Triplet Chemotherapy Combination With Cisplatin, Gemcitabine and Docetaxel in Patients With Chemotherapy‑naive Advanced Non-Small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Potential Role of Immunotherapy in Advanced Non-Small-Cell Lung Cancer
OncoTargets and Therapy
Oncology
Pharmacology
OA08 Efficacy and Safety of Sintilimab Combined With 1st Line Chemotherapy in Advanced Squamous Cell Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Predicting Survival in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer: Validating the Extent of Metastasis
Cancer Research and Treatment
Cancer Research
Oncology
Eastern Cooperative Oncology Group Experience With Chemotherapy in Advanced Non-Small Cell Lung Cancer
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
Refractory Non-Small-Cell Lung Cancer Responding to Combination Chemotherapy With Gemcitabine and Cisplatin
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
